Cargando…

Characterization of lipid parameters in diabetic and non-diabetic atherosclerotic patients

BACKGROUND & OBJECTIVE: The relationship between lipid profile perturbation and diabetes associated complications has long been an area of interest. Dyslipidemia is a potent predictor of cardiovascular morbidity and mortality in diabetic patients. The aim of present study was to investigate rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Fatima, Jamil, Hassan, Anwar, Sanam Saiqa, Wajid, Nadia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308457/ https://www.ncbi.nlm.nih.gov/pubmed/25678903 http://dx.doi.org/10.11909/j.issn.1671-5411.2015.01.005

Ejemplares similares

Comparison of Atherosclerotic Plaque Compositions in Diabetic and Non-diabetic Patients
por: Çakır, Mustafa Ozan, et al.
Publicado: (2023)

Characterization of lipid parameters in diabetes mellitus – a Nigerian report
por: Ogbera, Anthonia O, et al.
Publicado: (2009)

Evaluation of the value of conventional and unconventional lipid parameters for predicting the risk of diabetes in a non-diabetic population
por: Sheng, Guotai, et al.
Publicado: (2022)

Afamin Levels and Their Correlation with Oxidative and Lipid Parameters in Non-diabetic, Obese Patients
por: Juhász, Imre, et al.
Publicado: (2022)

Cardiac parameters affect prognosis in patients with non-large atherosclerotic infarction
por: Zeng, Ya-Ying, et al.
Publicado: (2021)

Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients
por: Chang, Jin-Biou, et al.
Publicado: (2011)

Effect of type 2 diabetic serum on the behavior of Wharton's jelly-derived mesenchymal stem cells in vitro
por: Ali, Fatima, et al.
Publicado: (2017)

Insulin Resistance Predicts Severity of Coronary Atherosclerotic Disease in Non-Diabetic Patients
por: Strisciuglio, Teresa, et al.
Publicado: (2020)

Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
por: Nelson, Adam J., et al.
Publicado: (2022)

Impact of the 2013 Cholesterol Guideline on Patterns of Lipid-Lowering Treatment in Patients with Atherosclerotic Cardiovascular Disease or Diabetes After 1 Year
por: Tran, Josephine N., et al.
Publicado: (2016)

Assessment of the Relationship between Lipid Parameters and Obesity Indices in Non-Diabetic Obese Patients: A Preliminary Report
por: Stępień, Anna, et al.
Publicado: (2014)

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
por: Omoto, Seitaro, et al.
Publicado: (2015)

Identification of Crucial Genes and Pathways Associated with Atherosclerotic Plaque in Diabetic Patients
por: Li, Yuan-Yuan, et al.
Publicado: (2021)

No detectable differential microRNA expression between non-atherosclerotic arteries of type 2 diabetic patients (treated or untreated with metformin) and non-diabetic patients
por: Steffensen, Lasse Bach, et al.
Publicado: (2018)

Impact of atherosclerotic extent on clinical outcome for diabetic patients with non-obstructive coronary artery disease
por: Liu, Zinuan, et al.
Publicado: (2021)

Severe Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease in Patients With Diabetes
por: Rana, Jamal S., et al.
Publicado: (2021)

Urinary pteridines as a discriminator of atherosclerotic risk in patients with diabetes
por: Marumo, Mikio, et al.
Publicado: (2021)

Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftment
por: Masoud, Muhammad Shareef, et al.
Publicado: (2012)

Impact of 3-year changes in lipid parameters and their ratios on incident type 2 diabetes: Tehran lipid and glucose study
por: Khaloo, Pegah, et al.
Publicado: (2018)

VEGF-B Levels in the Vitreous of Diabetic and Non-Diabetic Patients with Ocular Diseases and Its Correlation with Structural Parameters
por: Mesquita, Joana, et al.
Publicado: (2017)

Prognostic Value of Atherosclerotic Extent in Diabetic Patients with Nonobstructive Coronary Artery Disease
por: Ding, Yipu, et al.
Publicado: (2021)

Haematological parameters and lipid profile abnormalities among patients with Type-2 diabetes mellitus in Ghana
por: Antwi-Baffour, Samuel, et al.
Publicado: (2018)

Data on urinary pteridines as a discriminator of atherosclerotic risk in patients with diabetes
por: Marumo, Mikio, et al.
Publicado: (2022)

The predictive value of nontraditional lipid parameters for intracranial and extracranial atherosclerotic stenosis: a hospital-based observational study in China
por: Yu, Shun, et al.
Publicado: (2023)

Insulin Resistance in Relation to Lipids and Inflammation in Type-2 Diabetic Patients and Non-Diabetic People
por: Feng, Ying-Mei, et al.
Publicado: (2016)

Importance of lipid ratios for predicting intracranial atherosclerotic stenosis
por: Yang, Wen-Song, et al.
Publicado: (2020)

Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions
Publicado: (1990)

Association between serum visfatin levels and atherosclerotic plaque in patients with type 2 diabetes
por: Zheng, Long-Yi, et al.
Publicado: (2019)

Separate and combined associations of physical activity and obesity with lipid-related indices in non-diabetic and diabetic patients
por: Zhang, Yongliang, et al.
Publicado: (2019)

Coronary Atherosclerotic Plaque Detected by Computed Tomographic Angiography in Subjects with Diabetes Compared to Those without Diabetes
por: Khazai, Bahram, et al.
Publicado: (2015)

Serum free triiodothyronine is inversely associated with diabetic peripheral neuropathy but not with carotid atherosclerotic lesions in euthyroid patients with type 2 diabetes
por: Li, Mei-Fang, et al.
Publicado: (2021)

Ramadan and Diabetes: What About Non-Fasting Patients with Diabetes?
por: Motaib, Imane, et al.
Publicado: (2022)

Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels
por: Morales-Santana, Sonia, et al.
Publicado: (2013)

Comparison of pharmacokinetic parameters of ranolazine between diabetic and non-diabetic rats
por: Mashayekhi-sardoo, Habibeh, et al.
Publicado: (2022)

Association of sedentary time and carotid atherosclerotic plaques in patients with type 2 diabetes
por: Ke, Jing, et al.
Publicado: (2022)

Albuminuria Associates With Calcified Atherosclerotic Plaque in African Americans With Diabetes
por: Divers, Jasmin, et al.
Publicado: (2013)

Clinical Approach to Assessment and Amelioration of Atherosclerotic Vascular Disease in Diabetes
por: Goldberg, Ronald B.
Publicado: (2020)

Gycyrrhizic acid alleviates atherosclerotic lesions in rats with diabetes mellitus
por: Zhao, Yaodong, et al.
Publicado: (2021)

Diabetic Cystopathy Occurs Independently from Other Atherosclerotic Risks
por: Takahashi, Osamu, et al.
Publicado: (2021)

Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetes
por: Cai, Xiaoling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nqhgegpir2p3juu8qlp7s64qpj